Science Explorer Back to mapMap
Discussion
Hospital / health system · Rosario · Argentina

Instituto de Oncología de Rosario

In research, Instituto de Oncología de Rosario stands highest in Medicine (#11,186 of 14,558 worldwide) and Health Sciences (#13,130 of 16,688 worldwide), over all time.

World rank, all time
#33,308
of 34,923
Rank in Argentina
#176
of 178
Research works
212
▼ 17% vs 2018-21
Citations
3k
14.3 per fractional work
Top-10% rate
6.0%
all institutions 10.0%
vs its own fields
0.84×
1.00× is exactly expected
Open access
34%
world 40%
International
22%
world 18%

What is Instituto de Oncología de Rosario known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
MedicineField #11,186 of 14,558 7.9%141
Health SciencesDomain #13,130 of 16,688 7.8%150

Each strip is that field's whole ranked pool, with the notch where Instituto de Oncología de Rosario sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Instituto de Oncología de Rosario work in?

In 2022-now, 80% of research at Instituto de Oncología de Rosario is in Health Sciences, 14% in Life Sciences. Its largest fields are Medicine (76%), Biochemistry, Genetics and Molecular Biology (13%), Social Sciences (4%). It does 2.7× the world's share of Health Sciences.

Health Sciences: 23 fractional works · 79.6% of its workMedicine: 22 fractional works · 76.2% of its workOncology: 3 fractional works · 10.8% of its workSurgery: 3 fractional works · 10.7% of its workPulmonary and Respiratory Medicine: 3 fractional works · 9.3% of its workEndocrinology, Diabetes and Metabolism: 3 fractional works · 9.0% of its workPublic Health, Environmental and Occupational Health: 2 fractional works · 5.8% of its workNeurology: 1 fractional works · 4.9% of its workEpidemiology: 1 fractional works · 4.4% of its workReproductive Medicine: 1 fractional works · 4.2% of its workObstetrics and Gynecology: 1 fractional works · 2.8% of its workGenetics: 1 fractional works · 2.8% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 2.4% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 1.9% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 1.4% of its workPathology and Forensic Medicine: 0 fractional works · 1.3% of its workOtorhinolaryngology: 0 fractional works · 0.9% of its workDermatology: 0 fractional works · 0.7% of its workEmergency Medicine: 0 fractional works · 0.6% of its workPharmacology: 0 fractional works · 0.4% of its workPhysiology: 0 fractional works · 0.4% of its workAnesthesiology and Pain Medicine: 0 fractional works · 0.4% of its workHematology: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.6% of its workHealth Professions: 1 fractional works · 3.2% of its workGeneral Health Professions: 1 fractional works · 1.9% of its workEmergency Medical Services: 0 fractional works · 1.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workDentistry: 0 fractional works · 0.1% of its workLife Sciences: 4 fractional works · 14.2% of its workBiochemistry, Genetics and Molecular Biology: 4 fractional works · 13.1% of its workCancer Research: 2 fractional works · 5.7% of its workMolecular Biology: 1 fractional works · 3.8% of its workGenetics: 1 fractional works · 2.2% of its workBiotechnology: 0 fractional works · 1.0% of its workMolecular Medicine: 0 fractional works · 0.4% of its workNeuroscience: 0 fractional works · 0.7% of its workNeurology: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workImmunology and Microbiology: 0 fractional works · 0.4% of its workImmunology: 0 fractional works · 0.4% of its workSocial Sciences: 2 fractional works · 5.6% of its workSocial Sciences: 1 fractional works · 3.5% of its workDemography: 0 fractional works · 1.8% of its workSociology and Political Science: 0 fractional works · 1.2% of its workHealth: 0 fractional works · 0.6% of its workEconomics, Econometrics and Finance: 1 fractional works · 2.1% of its workEconomics and Econometrics: 1 fractional works · 2.1% of its workPhysical Sciences: 0 fractional works · 0.6% of its workChemistry: 0 fractional works · 0.3% of its workSpectroscopy: 0 fractional works · 0.3% of its workEngineering: 0 fractional works · 0.1% of its workMaterials Science: 0 fractional works · 0.1% of its workALL ITS WORKInstituto deOncología de…28fractional works, 2022-now
Life Sciences14%Physical Sciences1%Health Sciences80%Social Sciences6%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 11 fields, with their numbers
    1. Medicine2276.2%
    2. Health Professions13.2%
    3. Dentistry00.1%
    1. Biochemistry, Genetics and Molecular Biology413.1%
    2. Neuroscience00.7%
    3. Immunology and Microbiology00.4%
    1. Social Sciences13.5%
    2. Economics, Econometrics and Finance12.1%
    1. Chemistry00.3%
    2. Engineering00.1%
    3. Materials Science00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 2.45× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 0.43× its world share, 0 worksImmunology and Micro…Neuroscience: 0.44× its world share, 0 worksNeuroscienceChemistry: 0.20× its world share, 0 worksChemistryEngineering: 0.01× its world share, 0 worksEngineeringMaterials Science: 0.04× its world share, 0 worksMaterials ScienceDentistry: 0.27× its world share, 0 worksDentistryHealth Professions: 1.22× its world share, 1 worksHealth ProfessionsMedicine: 3.97× its world share, 22 worksMedicineEconomics, Econometrics and Finance: 0.98× its world share, 1 worksEconomics, Econometr…Social Sciences: 0.28× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.0×. Every wedge is a field page.

All 11 fields, with their numbers
  1. Medicine3.97×22 works
  2. Biochemistry, Genetics and Molecular Biology2.45×4 works
  3. Health Professions1.22×1 works
  4. Economics, Econometrics and Finance0.98×1 works
  5. Neuroscience0.44×0 works
  6. Immunology and Microbiology0.43×0 works
  7. Social Sciences0.28×1 works
  8. Dentistry0.27×0 works
  9. Chemistry0.20×0 works
  10. Materials Science0.04×0 works
  11. Engineering0.01×0 works

Who are the top researchers at Instituto de Oncología de Rosario?

Ranked on the quality score, Luis Enrique Fein, Raúl Sala and C. Blajman lead among researchers whose main affiliation is Instituto de Oncología de Rosario.

  1. 1 Luis Enrique Fein Argentina · #192,142 worldwide 12k citations · 91 works
  2. 2 Raúl Sala Argentina · #1,017,230 worldwide 800 citations · 22 works
  3. 3 C. Blajman Argentina · #1,025,810 worldwide 3.4k citations · 24 works
  4. 4 E. Mickiewicz Argentina · #1,373,782 worldwide 5.3k citations · 48 works
  5. 5 María Natalia Gandur Quiroga Argentina · #1,735,932 worldwide 45 citations · 15 works
  6. 6 R. Giglio Argentina · #1,833,090 worldwide 296 citations · 21 works
  7. 7 Valeria Cáceres Argentina · #2,149,607 worldwide 163 citations · 21 works
  8. 8 Rocío G. Sampayo Argentina · #2,639,908 worldwide 379 citations · 27 works
  9. 9 María Silvana Cugliari Argentina · #2,694,620 worldwide 224 citations · 17 works
  10. 10 Inés Califano Argentina · #3,129,780 worldwide 233 citations · 40 works
All ranked researchers at Instituto de Oncología de Rosario

What are the most cited papers from Instituto de Oncología de Rosario?

The most cited paper from Instituto de Oncología de Rosario is "Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer" (Karim S. Fizazi, NamPhuong Tran, Luis Enrique Fein et al., 2017), with 2,310 citations. Next come "Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial" (839) and "Planning cancer control in Latin America and the Caribbean" (505).

Most cited papers
#PaperReleasedCitations
1 Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer Karim S. Fizazi, NamPhuong Tran, Luis Enrique Fein et al. · New England Journal of Medicine Open access 4 Jun 2017 2,310
2 Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial Karim S. Fizazi, NamPhuong Tran, Luis Enrique Fein et al. · The Lancet Oncology Open access 12 Apr 2019 839
3 Planning cancer control in Latin America and the Caribbean Paul Edward Goss et al. · The Lancet Oncology Open access Apr 2013 505
4 Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer Charles E. Geyer et al. · Annals of Oncology Open access609 authors 10 Oct 2022 477
5 Efficacy and Safety of Ixabepilone (BMS-247550) in a Phase II Study of Patients With Advanced Breast Cancer Resistant to an Anthracycline, a Taxane, and Capecitabine Edith A. Perez, Guillermo Luis Lerzo, Xavier B. Pivot et al. · Journal of Clinical Oncology Open access 3 Jul 2007 393
All 60 most cited papers, with filters and sorting

Which keywords describe research at Instituto de Oncología de Rosario?

By fractional works in 2022-now, weighted toward what it does more of than the world: Immunotherapy, Chemotherapy, Radiotherapy, Survival Analysis, Molecular Classification, Epidemiology, Breast Cancer and Genetic Mutations.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 27 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 27 words, with their numbers
  1. Immunotherapy4▲ 18×16 topics
  2. Epidemiology3▲ 2.6×15 topics
  3. Chemotherapy2▲ 11×16 topics
  4. Radiotherapy2▲ 19×8 topics
  5. Survival Analysis2▲ 26×5 topics
  6. Molecular Classification2▲ 43×4 topics
  7. Breast Cancer2▲ 24×6 topics
  8. Genetic Mutations2▲ 13×7 topics
  9. Tumor Microenvironment2▲ 11×6 topics
  10. Cervical Cancer1▲ 45×3 topics
  11. Clinical Trials1▲ 7.2×5 topics
  12. Prognosis1▲ 15×3 topics
  13. Prognostic Factors1▲ 11×5 topics
  14. Quality of Life1▲ 3.5×9 topics
  15. Thyroid Carcinoma1▲ 94×2 topics
  16. BRAF Mutation1▲ 65×2 topics
  17. Clinical Practice Guidelines1▲ 8.5×5 topics
  18. Differentiated Thyroid Cancer1▲ 112×1 topic
  19. Thyroid Nodules1▲ 112×1 topic
  20. Autoantibodies1▲ 18×5 topics
  21. Diagnosis1▲ 4.6×6 topics
  22. Management1▲ 5.3×6 topics
  23. Infertility1▲ 25×2 topics
  24. Myasthenia Gravis1▲ 184×1 topic
  25. Robotic Surgery1▲ 24×3 topics
  26. Targeted Therapy1▲ 16×4 topics
  27. Thymic Tumors1▲ 184×1 topic

Which research topics does Instituto de Oncología de Rosario publish most on?

By volume in 2022-now: Thyroid Cancer Diagnosis and Treatment, Myasthenia Gravis and Thymoma, Cancer, Hypoxia, and Metabolism and Advanced Breast Cancer Therapies.

  1. 1 Thyroid Cancer Diagnosis and Treatment Endocrinology, Diabetes and Metabolism 1 works
  2. 2 Myasthenia Gravis and Thymoma Neurology 1 works
  3. 3 Cancer, Hypoxia, and Metabolism Cancer Research 1 works
  4. 4 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 1 works
  5. 5 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
  6. 6 Endometrial and Cervical Cancer Treatments Obstetrics and Gynecology 1 works
  7. 7 Thyroid Disorders and Treatments Endocrinology, Diabetes and Metabolism 1 works
  8. 8 Neuroendocrine Tumor Research Advances Epidemiology 1 works
  9. 9 Historical Studies in Latin America Demography 0 works
  10. 10 Ovarian function and disorders Reproductive Medicine 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available33.8%not open66.2%

World: 40% of research is openly available.

with international co-authors21.6%domestic only78.4%

World: 18% is written across borders.

How has Instituto de Oncología de Rosario's research output changed?

Output in 2022-2025 was 17% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Instituto de Oncología de Rosario as a percentage of every work published that year, 0.000095% in 2024.

still counting0.00050%0.0010%0.0015%Instituto de Oncología de Rosario0.00012% in 202519801990200020102020

Fractional works of Instituto de Oncología de Rosario over all fractional works that year. How the balance of science has shifted.

Other research institutions in Rosario

All research institutions in Rosario

Share Instituto de Oncología de Rosario's ranking

Instituto de Oncología de Rosario on Science Explorer

A card with Instituto de Oncología de Rosario's standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Instituto de Oncología de Rosario. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.